Skip to main content
SpringerLink
Log in

Third report of Tysabri-linked PML in commercial setting

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Biogen Idec Inc.United States Securities and Exchange Commission: FORM 8-K current report. Internet Document: [2 pages], 29 Oct 2008. Available from: URL: http://www.biogenidec.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Third report of Tysabri-linked PML in commercial setting. React. Wkly. 1227, 3 (2008). https://doi.org/10.2165/00128415-200812270-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812270-00006

Keywords

Search

Navigation